Pharsight

Merz Pharms patents expiration

1. Cuvposa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7638552 MERZ PHARMS Method for increasing the bioavailability of glycopyrrolate
Aug, 2023

(9 months ago)

US7816396 MERZ PHARMS Method for increasing the bioavailability of glycopyrrolate
Aug, 2023

(9 months ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE) Jul 28, 2017
New Product(NP) Jul 28, 2013

Drugs and Companies using GLYCOPYRROLATE ingredient

Market Authorisation Date: 28 July, 2010

Treatment: Reduce chronic severe drooling (i.e., sialorrhea) in patients with neurologic conditions associated with problem drooling

Dosage: SOLUTION;ORAL

How can I launch a generic of CUVPOSA before it's drug patent expiration?
More Information on Dosage

CUVPOSA family patents

Family Patents